Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4586 stock hub

TYO/4586 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/4586is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.7B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/4586
In the news

Latest news · TYO/4586

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/En/a
P25 11.7P50 15.2P75 22.3
ROE-44.5
P25 -1.6P50 7.1P75 11.9
ROIC-27.9
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/4586 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
176
Groups with data
11
Currency
JPY
Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
21
Employees Change
-1%
Employees Change Percent
-4.55
Enterprise value
JPY 2.9B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
JP3921220004
Last refreshed
2026-05-10
Market cap
JPY 4.7B
Price
JPY 79
Price currency
JPY
Rev Per Employee
6,095,238.1x
Sector
Healthcare
Sic
2834
Symbol
tyo/4586
Website
https://www.medrx.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-19.98%
EV Earnings
-3.13x
EV/FCF
-3.03x
EV/Sales
22.94x
FCF yield
-20.68%
P/B ratio
2.29x
P/S ratio
36.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
Gross margin
98.44%
Gross Profit
JPY 126M
Gross Profit Growth
-50.97%
Gross Profit Growth Q
350%
Gross Profit Growth3 Y
31.04%
Gross Profit Growth5 Y
2.57%
Net Income
JPY -937M
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Pretax Margin
-722.66%
Profit Per Employee
JPY -44.6M
ROA
-26.57
Roa5y
-30.54
ROCE
-45.29
ROE
-44.46
Roe5y
-53.03
ROIC
-27.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-23.23%
Cagr1y
25.42%
Cagr3y
-21.76%
Cagr5y
-19.45%
EPS Growth Quarters
2
EPS Growth Years
6
Revenue Growth
-50.2x
Revenue Growth Q
400x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
29.46x
Revenue Growth5 Y
2.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
JPY 0.06
Assets
JPY 2.2B
Cash
JPY 1.8B
Current Assets
JPY 1.8B
Current Liabilities
JPY 77M
Equity
JPY 2B
Liabilities
JPY 110M
Long Term Assets
JPY 333M
Long Term Liabilities
JPY 33M
Net Cash
JPY 1.8B
Net Cash By Market Cap
JPY 37.4
Net Cash Growth
-11.28%
Net Debt Equity
JPY -0.86
Tangible Book Value
JPY 2B
Tangible Book Value Per Share
JPY 34.48
WACC
7.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
23.69
Inventory Turnover
0.15
Net Working Capital
JPY -7M
Quick ratio
22.94
Working Capital
JPY 1.7B
Working Capital Turnover
JPY 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-23.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-92.89%
1Y total return
25.4%
200-day SMA
108.6
3Y total return
-52.12%
50-day SMA
96.12
50-day SMA vs 200-day SMA
50under200
5Y total return
-66.09%
All Time High
7,500
All Time High Change
-98.95%
All Time High Date
2013-05-08
All Time Low
55
All Time Low Change
43.64%
All Time Low Date
2025-04-07
ATR
4.32
Beta
0.53
Beta1y
-0.08
Beta2y
0.27
Ch YTD
-26.85
High
81
High52
225
High52 Date
2025-09-29
High52ch
-64.89%
Low
78
Low52
58
Low52 Date
2025-05-26
Low52ch
36.21%
Ma50ch
-17.81%
Price vs 200-day SMA
-27.28%
RSI
36.98
RSI Monthly
41.7
RSI Weekly
36.99
Sharpe ratio
0.65x
Sortino ratio
1.25
Total Return
-23.62%
Tr YTD
-26.85
Tr1m
-4.82%
Tr1w
-1.25%
Tr3m
-29.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
JPY -942M
Operating margin
-735.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
54,989,798%
Shares Insiders
5.74%
Shares Institutions
10.01%
Shares Out
59,365,098
Shares Qo Q
3.74%
Shares Yo Y
23.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
JPY -970M
Average Volume
567,500x
Bv Per Share
34.48
CAPEX
JPY -82M
Ch10y
-92.89
Ch1m
-4.82
Ch1w
-1.25
Ch1y
25.4
Ch3m
-29.46
Ch3y
-52.12
Ch5y
-66.09
Ch6m
-38.28
Change
0%
Change From Open
0
Close
79
Days Gap
0
Depreciation Amortization
13,000,000
Dollar Volume
25,943,600
Earnings Date
2026-05-15
EBIT
JPY -942M
EBITDA
JPY -929M
EPS
JPY -17.44
F Score
2
FCF
JPY -970M
FCF EV Yield
-33.04x
FCF Per Share
JPY -16.34
Financing CF
745,000,000
Fiscal Year End
December
Founded
2,002
Income Tax
JPY 12M
Investing CF
-82,000,000
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Ma150
114
Ma150ch
-30.69%
Ma20
83.1
Ma20ch
-4.93%
Net CF
-222,000,000
Next Earnings Date
2026-05-15
Open
79
Position In Range
33.33
Ppne
192,000,000
Price Date
2026-05-08
Ptbv Ratio
2.29
Relative Volume
0.53x
Revenue
128,000,000x
Tax By Revenue
9.38x
Tr6m
-38.28%
Volume
328,400
Z Score
25.21
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TYO/4586 pay a dividend?

Capital-return profile for this ticker.

Performance

TYO/4586 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+25.4%
S&P 500 1Y: n/a
3Y total return
-52.1%
S&P 500 3Y: n/a
5Y total return
-66.1%
S&P 500 5Y: n/a
10Y total return
-92.9%
S&P 500 10Y: n/a
Ownership

Who owns TYO/4586?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.0%
Share of float held by funds and institutions
Insider ownership
+5.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+23.6%
Negative means the company is buying back shares.
Technical

TYO/4586 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
37.0
Neutral momentum band
Price vs 200-day MA
-27.3%
50/200-day relationship not available
Beta (5Y)
0.53
Less volatile than the market
Sharpe ratio
0.65
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/4586

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4586 stock rating?

tyo/4586 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4586 analysis?

The full report lives at /stocks/tyo/4586/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4586?

The latest report frames tyo/4586 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4586 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.